Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Endocannabinoids in basal ganglia circuits: implications for Parkinson disease.

× No keyword cloud information.

21 in total

Review 1. Cannabis in the Treatment of Dystonia, Dyskinesias, and Tics.

Authors: Barbara S Koppel
Journal: Neurotherapeutics Date: 2015-10 Impact factor: 7.620

Review 2. Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson's Disease and L-DOPA-Induced Dyskinesia.

Authors: Nilson Carlos Ferreira Junior; Maurício Dos-Santos-Pereira; Francisco Silveira Guimarães; Elaine Del Bel
Journal: Neurotox Res Date: 2019-10-22 Impact factor: 3.911

3. Species differences in cannabinoid receptor 2 and receptor responses to cocaine self-administration in mice and rats.

Authors: Hai-Ying Zhang; Guo-Hua Bi; Xia Li; Jie Li; Hong Qu; Shi-Jian Zhang; Chuan-Yun Li; Emmanuel S Onaivi; Eliot L Gardner; Zheng-Xiong Xi; Qing-Rong Liu
Journal: Neuropsychopharmacology Date: 2014-11-06 Impact factor: 7.853

Review 4. The management of tics.

Authors: David Shprecher; Roger Kurlan
Journal: Mov Disord Date: 2009-01-15 Impact factor: 10.338

Review 5. The therapeutic potential of cannabinoids for movement disorders.

Authors: Benzi Kluger; Piera Triolo; Wallace Jones; Joseph Jankovic
Journal: Mov Disord Date: 2015-02-04 Impact factor: 10.338

Review 6. The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease.

Authors: Nicola Barrie; Nicholas Manolios
Journal: Eur J Rheumatol Date: 2017-09-01

7. More evidence of cannabis efficacy in restless legs syndrome.

Authors: Imad Ghorayeb
Journal: Sleep Breath Date: 2019-12-09 Impact factor: 2.816

8. Medicinal Cannabis for Parkinson's Disease: Practices, Beliefs, and Attitudes Among Providers at National Parkinson Foundation Centers of Excellence.

Authors: Danny Bega; Tanya Simuni; Michael S Okun; Xinguang Chen; Peter Schmidt
Journal: Mov Disord Clin Pract Date: 2016-05-20

Review 9. Cannabis for Restless Legs Syndrome.

Authors: Imad Ghorayeb
Journal: Adv Exp Med Biol Date: 2021 Impact factor: 2.622

10. Medium-throughput zebrafish optogenetic platform identifies deficits in subsequent neural activity following brief early exposure to cannabidiol and Δ⁹-tetrahydrocannabinol.

Authors: Richard Kanyo; Md Ruhul Amin; Laszlo F Locskai; Danika D Bouvier; Alexandria M Olthuis; W Ted Allison; Declan W Ali
Journal: Sci Rep Date: 2021-06-01 Impact factor: 4.379

Endocannabinoids in basal ganglia circuits: implications for Parkinson disease.